Xencor (XNCR) Operating Income Growth (3y) (2016 - 2026)
Xencor (XNCR) Operating Income Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 55.96% |
| 10 | Xencor | 1.49 Bn | 1.11 Bn | - | -8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.63% |
| Dec 31, 2025 | -7.98% |
| Sep 30, 2025 | -7.41% |
| Jun 30, 2025 | -5.81% |
| Mar 31, 2025 | -53.71% |
| Dec 31, 2024 | -28.94% |
| Sep 30, 2024 | -10.15% |
| Jun 30, 2024 | -100.77% |
| Mar 31, 2024 | -51.65% |
| Dec 31, 2023 | -25.92% |
| Sep 30, 2023 | -3.00% |
| Jun 30, 2023 | 11.57% |
| Mar 31, 2023 | -90.57% |
| Dec 31, 2022 | -11.69% |
| Sep 30, 2022 | -39.01% |
| Jun 30, 2022 | -12.68% |
| Mar 31, 2022 | -30.32% |
| Dec 31, 2021 | 85.15% |
| Sep 30, 2021 | -302.98% |
| Jun 30, 2021 | 32.41% |